Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

IST/MEDTR stock hub

IST/MEDTR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IST/MEDTRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.8B

Istanbul Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IST/MEDTR

In the news

Latest news · IST/MEDTR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 13.7P50 15.1P75 15.3

Trailing P/En/a

P25 16.6P50 25.2P75 56.6

ROE-0.4

P25 -2.4P50 3.5P75 11.2

ROIC4.3

P25 -0.7P50 4.3P75 13.6

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IST/MEDTR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

TRY

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Turkey
Country code	TR
Employees	796
Employees Change	31%
Employees Change Percent	4.05
Enterprise value	TRY 3.4B
Exchange	Istanbul Stock Exchange
Financial currency	TRY
First seen	2026-05-10
Industry	Medical Devices
Isin	TREMDTR00028
Last refreshed	2026-05-10
Market cap	TRY 3.8B
Price	TRY 31.58
Price currency	TRY
Rev Per Employee	3,610,090.87x
Sector	Healthcare
Sic	3841
Symbol	ist/MEDTR
Website	https://www.meditera.com.tr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.25%
EV Earnings	-370.39x
EV/EBIT	40.56x
EV/EBITDA	13.15x
EV/FCF	13.69x
EV/Sales	1.2x
FCF yield	6.67%
P/B ratio	1.28x
P/S ratio	1.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.7%
EBITDA Margin	9.51%
FCF margin	8.73%
Gross margin	28.7%
Gross Profit	TRY 824.7M
Gross Profit Growth	-19.99%
Gross Profit Growth Q	-12.73%
Gross Profit Growth3 Y	7.74%
Gross Profit Growth5 Y	39.1%
Net Income	TRY -9.3M
Net Income Growth Q	320.34%
Pretax Margin	-0.56%
Profit Margin	-0.32%
Profit Per Employee	TRY -11,648
ROA	1.83
Roa5y	9.4
ROCE	3.48
ROE	-0.4
Roe5y	11.79
ROIC	4.29
Roic5y	21.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	0.82%
Cagr3y	6.67%
Div CAGR3	-12.43%
EPS Growth Q	323.1
FCF Growth	-53.08%
FCF Growth Q	-90.14%
FCF Growth5 Y	36.77%
OCF Growth	-44.24%
OCF Growth Q	-57.73%
OCF Growth3 Y	109.78%
OCF Growth5 Y	42.82%
Revenue Growth	4.83x
Revenue Growth Q	12.02x
Revenue Growth3 Y	21.66x
Revenue Growth5 Y	51.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TRY 0.79
Assets	TRY 3.6B
Cash	TRY 386.4M
Current Assets	TRY 1.8B
Current Liabilities	TRY 541.5M
Debt	TRY 38.9M
Debt EBITDA	TRY 0.14
Debt Equity	TRY 0.01
Debt FCF	TRY 0.16
Equity	TRY 2.9B
Interest Coverage	2.24
Liabilities	TRY 661.1M
Long Term Assets	TRY 1.8B
Long Term Liabilities	TRY 119.6M
Net Cash	TRY 347.5M
Net Cash By Market Cap	TRY 9.25
Net Cash Growth	-31.44%
Net Debt EBITDA	TRY -1.27
Net Debt Equity	TRY -0.12
Net Debt FCF	TRY -1.39
Tangible Book Value	TRY 2.8B
Tangible Book Value Per Share	TRY 23.75
WACC	7.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.36
Inventory Turnover	3.29
Net Working Capital	TRY 918.5M
Quick ratio	2.19
Working Capital	TRY 1.3B
Working Capital Turnover	TRY 2.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	135.01%
Dividend Growth Years	0%
Dividend per share	TRY 0.25
Dividend Years	5
Dividend Yield	0.8%
Ex Div Date	2026-07-29
Last Dividend	TRY 0.11
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	0.82%
200-day SMA	29.94
3Y total return	21.37%
50-day SMA	28.95
50-day SMA vs 200-day SMA	50under200
All Time High	55
All Time High Change	-42.58%
All Time High Date	2025-01-09
All Time Low	8.71
All Time Low Change	262.41%
All Time Low Date	2021-07-14
ATR	1.06
Beta	0.41
Beta1y	0.21
Beta2y	0.39
Ch YTD	9.81
High	34.48
High52	37.96
High52 Date	2025-08-13
High52ch	-16.81%
Low	31.48
Low52	25.52
Low52 Date	2025-06-18
Low52ch	23.75%
Ma50ch	9.09%
Price vs 200-day SMA	5.48%
RSI	65.78
RSI Monthly	48.38
RSI Weekly	56.14
Sharpe ratio	0.07x
Sortino ratio	0.26
Total Return	0.8%
Tr YTD	9.81
Tr1m	12.15%
Tr1w	4.71%
Tr3m	6.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TRY 106.2M
Operating Income Growth	-65.09
Operating Income Growth3 Y	-34.94
Operating Income Growth5 Y	1.01
Operating margin	3.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	24,499,426%
Net Borrowing	-29,761,614
Shares Insiders	79.41%
Shares Institutions	5.16%
Shares Out	119,000,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TRY 250.8M
Average Volume	902,669.35x
Bv Per Share	24.42
CAPEX	TRY -184.6M
Ch1m	12.15
Ch1w	4.71
Ch3m	6.4
Ch3y	19.62
Ch6m	11.2
Change	-1%
Change From Open	-2.77
Close	31.9
Days Gap	1.82
Depreciation Amortization	167,061,180
Dollar Volume	138,489,447.7
Earnings Date	2026-05-14
EBIT	TRY 106.2M
EBITDA	TRY 273.3M
EPS	TRY -0.08
F Score	4
FCF	TRY 250.8M
FCF EV Yield	7.3x
FCF Per Share	TRY 2.11
Financing CF	-270,299,669
Fiscal Year End	December
Founded	1,983
Goodwill	64,536,480
Income Tax	TRY -4.4M
Investing CF	171,616,906
Is Primary Listing	1
Last Earnings Date	2026-02-20
Last Report Date	2025-12-31
Last Split Date	2022-02-22
Last Split Type	Forward
Ma150	29.12
Ma150ch	8.46%
Ma20	29.96
Ma20ch	5.39%
Net CF	-79,693,113
Next Earnings Date	2026-05-14
Open	32.48
P FCF Ratio	14.98
P OCF Ratio	8.63
Payment Date	2026-07-31
Position In Range	3.33
Ppne	1,605,549,469
Price Date	2026-05-08
Price EBITDA	TRY 13.75
Ptbv Ratio	1.33
Relative Volume	4.86x
Revenue	2,873,632,332x
Tax By Revenue	-0.15x
Tr6m	11.53%
Volume	4,385,353
Z Score	5.36

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

IST/MEDTR dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$0.25 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.8%

Next ex-dividend date: 2026-07-29

Performance

IST/MEDTR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IST/MEDTR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.2%

Share of float held by funds and institutions

Insider ownership

+79.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

IST/MEDTR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.8

Neutral momentum band

Price vs 200-day MA

+5.5%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IST/MEDTR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ist/MEDTR stock rating?

ist/MEDTR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ist/MEDTR analysis?

The full report lives at /stocks/ist/MEDTR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ist/MEDTR?

The latest report frames ist/MEDTR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ist/MEDTR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.